AwardedBelgiumGoodsFramework agreement
Omalizumab
- Published
- Published 26 March 2026
- Deadline
- Closed 29 April 2026
Overview
VITAZ vzw has awarded a framework agreement for the supply of Omalizumab pharmaceutical product to Novartis Pharma for EUR 388,000. The contract, awarded on 1 June 2026, establishes the terms and conditions for on-demand delivery of the medicine throughout the agreement period as specified in the technical specifications.
Key details
- Country
- Belgium
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 26 March 2026
- Deadline
- Closed
Various medicinal products
Award outcome
- Awarded value
- €388,000
- Award date
- 1 June 2026
- Contract period
- — → 11 May 2030
- NOVARTIS PHARMA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 June 2026
Contract Notice
26 March 2026
Contracting authority
VITAZ vzw
Procuring entitySint-Niklaas, Belgium
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.